Semaglutide is a medically approved weight loss medication. It is the first and only medication for obesity to be approved at a higher dose than the one used for diabetes treatment. The medication is marketed under the brand name Wegovy.

​

The Semaglutide Injection works by reducing appetite, increasing feelings of fullness, and slowing down stomach emptying. This leads to a reduction in food intake, which can help with weight loss.

​

In clinical trials, semaglutide has been shown to be effective in helping people with obesity lose a significant amount of weight. Studies have found that people who take semaglutide along with a reduced-calorie diet and increased physical activity lose more weight than those who follow the same diet and exercise regimen alone. The medication has also been shown to improve other health markers such as blood pressure, blood sugar control, and cholesterol levels.

​

As with any medication, semaglutide does have potential side effects, including nausea, diarrhea, and constipation. It may also increase the risk of certain types of thyroid cancer, although this risk appears to be very low.